GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Beijing Airdoc Technology Co Ltd (HKSE:02251) » Definitions » Cash Flow from Financing

Beijing Airdoc Technology Co (HKSE:02251) Cash Flow from Financing : HK$-20.3 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Beijing Airdoc Technology Co Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2023, Beijing Airdoc Technology Co paid HK$0.0 Mil more to buy back shares than it received from issuing new shares. It received HK$0.0 Mil from issuing more debt. It paid HK$0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received HK$0.0 Mil from paying cash dividends to shareholders. It received HK$0.0 Mil on other financial activities. In all, Beijing Airdoc Technology Co spent HK$0.0 Mil on financial activities for the six months ended in Dec. 2023.


Beijing Airdoc Technology Co Cash Flow from Financing Historical Data

The historical data trend for Beijing Airdoc Technology Co's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Airdoc Technology Co Cash Flow from Financing Chart

Beijing Airdoc Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
68.32 285.25 1,901.61 -19.14 -20.27

Beijing Airdoc Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only 1,594.45 -0.60 -18.57 -3.28 -16.99

Beijing Airdoc Technology Co Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Beijing Airdoc Technology Co's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Beijing Airdoc Technology Co's Cash from Financing for the quarter that ended in Dec. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-20.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Airdoc Technology Co  (HKSE:02251) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Beijing Airdoc Technology Co's issuance of stock for the six months ended in Dec. 2023 was HK$0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Beijing Airdoc Technology Co's repurchase of stock for the six months ended in Dec. 2023 was HK$0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Beijing Airdoc Technology Co's net issuance of debt for the six months ended in Dec. 2023 was HK$0.0 Mil. Beijing Airdoc Technology Co received HK$0.0 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Beijing Airdoc Technology Co's net issuance of preferred for the six months ended in Dec. 2023 was HK$0.0 Mil. Beijing Airdoc Technology Co paid HK$0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Beijing Airdoc Technology Co's cash flow for dividends for the six months ended in Dec. 2023 was HK$0.0 Mil. Beijing Airdoc Technology Co received HK$0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Beijing Airdoc Technology Co's other financing for the six months ended in Dec. 2023 was HK$0.0 Mil. Beijing Airdoc Technology Co received HK$0.0 Mil on other financial activities.


Beijing Airdoc Technology Co Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Beijing Airdoc Technology Co's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Airdoc Technology Co (HKSE:02251) Business Description

Traded in Other Exchanges
N/A
Address
West Third Ring North Road, Room 21, 4th Floor, Building 2, A2 Yard, Haidian District, Beijing, CHN
Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue principally from the provision of AI-based software solutions, sales of hardware devices and other services.
Executives
Mialkos Tomasz Jakub 2101 Beneficial owner
Zhang Dalei 2501 Other
Fosun Holdings Limited 2201 Interest of corporation controlled by you
Yadong Beichen Venture Investment Co., Ltd. 2101 Beneficial owner
Shanghai Ruikun Venture Capital Investment Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Fosun Industrial Investment Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd. 2201 Interest of corporation controlled by you
Guo Guangchang 2201 Interest of corporation controlled by you
Fosun International Limited 2201 Interest of corporation controlled by you
Fosun International Holdings Ltd. 2201 Interest of corporation controlled by you
Chen Mingqiang 2501 Other
Gao Fei 2501 Other
Niagara Falls Holding Limited 2101 Beneficial owner
China Life Franklin Asset Management Co., Limited
China Life Insurance (group) Company

Beijing Airdoc Technology Co (HKSE:02251) Headlines

No Headlines